This page contains public information about Pfizer’s financial performance in 2021
Pfizer's revenue doubled in 2021 compared to the previous 2 years.
The additional $15B in funding to Pfizer and Moderna was removed from the spending bill last week. This was in addition to what's was spent in 2021. This additional funding will be tied to another spending bill, these clowns know now to play the game, they'll get this funding in another spending bill.
Pfizer is expecting revenue from Covid vaccinations in 2022 to be $54B ($32B in shots, $22B in Plaxlovid pill) and a total revenue of $98B-$102B in 2022.
Covid business is good business.